Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
477 Leser
Artikel bewerten:
(2)

Amcomri Entertainment Inc.: Amcomri Entertainment Announces Results of Annual General Meeting

VANCOUVER, British Columbia, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. ("Amcomri" or the "Company") (NEO: AMEN) (Frankfurt: 25YO) (OTC: AMNNF), is pleased to provide the results of the annual general meeting of shareholders of Amcomri (the "Meeting") held earlier today. A total of 15,180,153 common shares of the Company, representing approximately 20.62% of the issued and outstanding common shares, were represented in person or by proxy at the Meeting.

At the Meeting, the number of directors of the Company was fixed at eight and each of the eight nominees proposed by management was elected to serve as a director of the Company, to hold office until the close of the next annual meeting of shareholders or until his or her successor is elected or appointed. Detailed results of the votes are set out below:

Nominee Votes For Votes Withheld/Abstain
NumberPercentage (%) NumberPercentage (%)
Paul McGowan 14,157,02399.95 7,6400.05
Robert Price 14,157,02399.95 7,6400.05
Larry Howard 14,156,96599.95 7,6980.05
Martin Andrew Lyon 14,157,02399.95 7,6400.05
Michael Walker 12,857,980 90.78 1,306,6839.22
Michèle Maheux 14,164,283100.00 3800.00
Janet Grove 14,164,283100.00 3800.00
Alex Stojanovic 14,164,225100.00 4380.00

Amcomri's shareholders also voted in favour of reappointing MNP LLP as the Company's auditors for the ensuing year and authorized the directors to fix their remuneration.

Paul McGowan, Non-Executive Chairman of Amcomri, commented, "We're thrilled to welcome Janet Grove to our team as a valuable addition to our board of directors. Janet's background and experience will be integral to our continued development and the delivery of our strategic growth plan".

Ms. Grove is a corporate lawyer and partner at Norton Rose Fulbright Canada LLP where she is Canadian head of their Life Sciences and Healthcare Group. Ms. Grove was previously managing partner of Vancouver based law firm, Bull, Housser & Tupper LLP and led Bull, Housser in its merger discussions with global law firm, Norton Rose Fulbright. She then served as managing partner of Norton Rose Fulbright's Vancouver office until her term expired at the end of 2019. She was named one of Canada's Top 100 Most Powerful Women in 2017 by Women's Executive Network and appointed King's Counsel in 2020. Ms. Grove also currently serves on the board of Genome BC and sits on the Audit and Assurance Standards Council of Canada.

About Amcomri Entertainment Inc.

Amcomri Entertainment Inc. (NEO: AMEN) (Frankfurt: 25Y0) provides global distribution capabilities for independent movie, documentary and TV series producers as well as for its own in-house productions. With decades of experience across all key media platforms, Amcomri is rapidly becoming the go-to team for independent producers seeking the broadest possible audience for their productions. The Amcomri Entertainment Inc. group of companies includes 101 Films, 101 Films International, Hollywood Classics International, Amcomri Productions, Appreciated Media Global, Amcomri Productions and Abacus Media Rights.

For further information about Amcomri, see its disclosure documents on SEDAR at www.sedar.com or visit the company's website at https://amcomrientertainmentinc.com/

For more information, please contact:

Larry HowardPierre Boucher
Amcomri, Chief Financial Officer MBC Capital Markets Advisors
Email: larry.howard@amcomri.comEmail: pierre@maisonbrison.com
Phone: +353-87-686-8255Phone: 1-514-731-0000

© 2023 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.